CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma

Authors :: Christian H. Ottensmeier
Emma Kirkpatrick
Daniel T Barnes
Stephanie Hill
Jason F. Lester
Gareth Griffiths
Kelly Cozens
Tom Maishman
Gerard G Hanna
Dean A. Fennell
Sarah Danson
Joanne Lord
Mavis Nye
Nicola Steele
Karan D Vadher
Peter W. Szlosarek
Source :: Journal of Clinical Oncology. 36:TPS8586-TPS8586
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: TPS8586Background: Mesothelioma, an incurable, apoptosis-resistant cancer, represents a growing health burden but remains under-researched, with limited treatment options. Despite a significant num...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Cancer
Treatment options
medicine.disease
Placebo
respiratory tract diseases
law.invention
Randomized controlled trial
law
Internal medicine
medicine
Mesothelioma
Nivolumab
business

Full Text Access

Tools